Next year is shaping up to be a bad year for Pfizer, and the markets know it. Shares of Pfizer are down after the company announced a forecasted revenue slump in 2024 amid declining demand for the company's Wuhan coronavirus (COVID-19) "vaccine" and other related products. In a press release entitled "Pfizer Provides Full-Year 2024 Guidance," the company … Continue reading Pfizer shares PLUNGE as gloomy 2024 economic outlook emerges
Dr. Eddy Bettermann MD 